Nucleic Acid Therapeutics CDMO Market – A Global and Regional Analysis bisresearch.com
The global nucleic acid therapeutics CDMO market is expected to reach $4,463.7 Million by 2030, with a CAGR of 11.09 % during the forecast period 2021-2030.
Factors driving the growth of the global nucleic acid therapeutics CDMO market are accelerating shift of the pharmaceutical market toward innovative biologic and cell and gene therapy products, reduction in overall manufacturing cost at CDMOs, and rising approvals of nucleic acid therapeutics.
The potential opportunities that are likely to boost the growth of the global nucleic acid therapeutics CDMO market are increasing outsourcing trend among pharmaceutical companies, accelerating research and development along with technology, and growth in developing countries.
Report Story